Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2013-04-22 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a short announcement from CSPC Pharmaceutical Group Limited stating the date of a forthcoming Board meeting to approve quarterly results for the three months ended 31 March 2013. It does not contain any financial data or the results themselves, only the notice of the meeting date. The document length is only 1301 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, announcements about upcoming board meetings to approve quarterly results are typically classified as Regulatory Filings (RNS) because they are general regulatory announcements and do not contain substantive financial data or detailed reports. Therefore, the appropriate classification is Regulatory Filings (RNS).
2013-04-22 English
Proxy Form for use at the Annual General Meeting to be held on Thursday, 23 May 2013 at 10:00 a.m. (and at any adjournment thereof)
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for use at the Annual General Meeting (AGM) of Pharmaceutical Group Limited, scheduled for 23 May 2013. It includes instructions for shareholders to appoint proxies to vote on various resolutions such as receiving audited financial statements, re-electing directors, declaring dividends, and authorizing share repurchases and issuances. The content is clearly related to the AGM process and voting procedures, not the actual AGM materials or reports themselves. Therefore, this document fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2013-04-18 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a Notice of Annual General Meeting (AGM) for CSPC Pharmaceutical Group Limited. It includes details about the meeting date, agenda items such as receiving audited financial statements, re-election of directors, dividend declaration, and approval of share repurchase and allotment mandates. The content is typical of an AGM notice, which is a formal announcement to shareholders about the upcoming meeting and the matters to be discussed and voted on. It does not contain the actual financial statements or detailed reports but rather the notice to convene the meeting. Therefore, it fits the category of AGM Information (AGM-R). The document length is over 11,000 characters, which is consistent with a detailed AGM notice rather than a brief announcement or proxy statement.
2013-04-18 English
PROPOSALS FOR GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES,RE-ELECTION OF THE RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a circular from CSPC Pharmaceutical Group Limited dated April 19, 2013, containing detailed proposals for the Annual General Meeting (AGM) scheduled for May 23, 2013. It includes proposals for general mandates to repurchase shares and to issue shares, re-election of retiring directors, and the notice of the AGM itself. The document contains explanatory statements, details of directors proposed for re-election, and the full notice of the AGM. It is not a financial report, earnings release, or audit report, but rather a comprehensive information circular sent to shareholders to inform them about the AGM agenda and related resolutions. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. The document is lengthy (15,000 characters) and contains substantive content, not merely an announcement or notice of report publication. Therefore, the appropriate classification is AGM Information (AGM-R).
2013-04-18 English
Annual Report 2012
Annual Report Classification · 100% confidence The document is titled '2012 Annual Report' and contains detailed sections typical of an annual report, including Chairman's Statement, Management Discussion and Analysis, Corporate Governance Report, Directors' Report, Independent Auditor's Report, and comprehensive financial statements such as Consolidated Statement of Comprehensive Income, Statement of Financial Position, and Notes to the Consolidated Financial Statements. The length is substantial (15,000 characters), indicating it is the full report rather than an announcement. The content includes detailed financial performance, business overview, strategic transformation, and outlook, all consistent with an official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2012
2013-04-18 English
GRANT OF SHARE OPTIONS
Capital/Financing Update Classification · 100% confidence The document is an announcement from CSPC Pharmaceutical Group Limited regarding the grant of options to subscribe for new shares under the Share Option Scheme. It details the number of shares, exercise price, grant date, and recipients including directors. The document is an announcement of a share option grant, which is a capital-related update but not a full financial report or earnings release. It does not contain financial statements or detailed financial analysis. The content fits the category of Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through share options.
2013-04-18 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.